Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.79M Sell
11,320
-694
-6% -$220K 0.15% 140
2026
Q1
$3.01M Buy
12,014
+200
+2% +$44.4K 0.13% 150
2025
Q4
$1.91M Buy
11,814
+26
+0.2% +$4.51K 0.08% 214
2025
Q3
$1.78M Buy
11,788
+1,957
+20% +$261K 0.08% 230
2025
Q2
$1.26M Sell
9,831
-3,216
-25% -$313K 0.06% 282
2025
Q1
$942K Buy
13,047
+6,285
+93% +$669K 0.05% 341
2024
Q4
$768K Buy
6,762
+527
+8% +$62.6K 0.04% 390
2024
Q3
$620K Buy
6,235
+610
+11% +$50.6K 0.03% 435
2024
Q2
$487K Buy
5,625
+1,060
+23% +$96.5K 0.03% 495
2024
Q1
$373K Buy
+4,565
New +$287K 0.02% 597

Other funds holding VRT

Moors & Cabot's VRT Position: Q2 2026 in Review

Moors & Cabot reduced its Vertiv (VRT) stake by 5.8% in Q2 2026, selling an estimated $220K and leaving 11,320 shares worth $3.79M. The position accounts for 0.15% of the portfolio, ranked #140.

Moors & Cabot first reported a position in VRT in Q1 2024 and has held it in 10 quarters since. 2,061 funds tracked by Wall St. Rank hold VRT as of Q2 2026.

  • Moors & Cabot held 11,320 shares of Vertiv worth $3.79M as of Q2 2026.
  • Moors & Cabot sold 694 Vertiv shares in Q2 2026, an estimated $220K.
  • Vertiv made up 0.15% of Moors & Cabot's portfolio in Q2 2026, its #140 holding.
  • Moors & Cabot first reported a position in Vertiv in Q1 2024 and has held it in 10 quarters since.
  • 2,061 funds tracked by Wall St. Rank held Vertiv as of Q2 2026.

Based on Moors & Cabot's 13F filing for Q2 2026, filed 10 Aug 2026.